⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for alk rearrangement

Every month we try and update this database with for alk rearrangement cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
ALK Tyrosine Kinase Inhibitors in ALK-rearranged Advanced Squamous Cell CarcinomaNCT05014464
Non-small Cell ...
Crizotinib
18 Years - Hunan Province Tumor Hospital
Blood-based Identification and Monitoring of Patients With ALK-translocated Lung CancerNCT02718651
Carcinoma, Non-...
18 Years - University of Aarhus
Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLCNCT05681780
Non Small Cell ...
Stage IV Non-sm...
Recurrent Non S...
Tumor-infiltrat...
Nivolumab
Cyclophosphamid...
Fludarabine
Tumor-infiltrat...
Interleukin-2 (...
18 Years - H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)NCT03944772
Non-Small Cell ...
Osimertinib
Savolitinib
Gefitinib
Necitumumab
Durvalumab
Carboplatin
Pemetrexed
Alectinib
Selpercatinib
Selumetinib
Etoposide
Cisplatin
Datopotamab der...
18 Years - 130 YearsAstraZeneca
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: